Lidex-E (Topical application)
Generic name:fluocinonide (topical application route) [ floo-oh-SIN-oh-nide ]
Drug class:Topical steroids
Medically reviewed by Drugs.com. Last updated on Jun 15, 2022.
The Lidex-E brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
Commonly used brand name(s)
In the U.S.
- Lidex
- Lidex-E
- Vanos
In Canada
- Lidemol
- Lidex Mild
- Lidex Regular
- Lyderm
- Tcis
- Tiamol
- Topsyn
- Trisyn
Available Dosage Forms:
- Cream
- Gel/Jelly
- Ointment
- Emollient Cream
- Solution
Therapeutic Class: Corticosteroid, Strong
Pharmacologic Class: Adrenal Glucocorticoid
Uses for Lidex-E
Fluocinonide topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. This medicine is a corticosteroid (cortisone-like medicine or steroid).
This medicine is available only with your doctor's prescription.
Before using Lidex-E
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of fluocinonide topical in the pediatric population. However, because of this medicine's toxicity, it should be used with caution. Children may absorb large amounts through the skin, which can cause serious side effects. If your child is using this medicine, follow your doctor's instructions very carefully. For Vanos® cream, safety and efficacy have not been established in children younger than 12 years of age.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of Vanos® cream in the elderly. However, elderly patients are more likely to have age-related medical problems, which may require caution in patients receiving Vanos® cream.
No information is available on the relationship of age to the effects of fluocinonide topical in geriatric patients.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medic...